Emerson Electric Co.

(New York Stock Exchange)
Back to all articles
Neutral 0

Investors Heavily Search Emerson Electric Co. (EMR): Here is What You Need to Know

AI-generated analysis

πŸ“‰ Emerson Electric (EMR) shares dropped 17.3% over the past month, significantly underperforming the -6.2% decline of the S&P 500 composite.

🏭 The Zacks Manufacturing - Electronics industry declined 9.1% during the same period as EMR stock.

πŸ“Š Sell-side analysts project EPS of $1.55 for the current quarter, reflecting a +4.7% year-over-year change.

πŸ’Ή Consensus earnings estimates indicate a fiscal year growth of +8.3% and a next fiscal year increase of +9.8%.

πŸ€– Revisions to Zacks consensus earnings estimates have been slight over the last month across all forecast periods.

πŸ› οΈ Emerson Electric is primarily engaged in manufacturing process controls systems, valves, and analytical instruments.

πŸ’° Current quarter sales estimates reach $4.62 billion, projecting +4.3% year-over-year revenue growth.

πŸ“ˆ Reported revenues of $4.35 billion last quarter showed +4.1% growth and met consensus EPS expectations with a +3.55% surprise.

πŸ† The company exceeded consensus EPS estimates three times over the last four quarters but only topped revenue estimates once.

πŸ’΅ Valuation metrics indicate EMR is trading at a premium to peers, resulting in a Zacks Value Style Score of D.

πŸ“‰ Based on earnings estimate revisions and other factors, Emerson Electric currently holds a Zacks Rank of #3 (Hold).

🧠 Analysis suggests the stock may perform in line with the broader market given its current neutral rating.

Bullish Signals
  • Emerson Electric is expected to post earnings of $1.55 per share for the current quarter, representing a year-over-year increase of +4.7%.
  • The consensus sales estimate for the current quarter points to a year-over-year change of +4.3%, with fiscal year estimates indicating changes of +5.4% and +4.7% for the current and next fiscal years, respectively.
  • Emerson Electric reported revenues of $4.35 billion in the last reported quarter, representing a year-over-year growth of +4.1% compared to $1.38 per share in EPS.
  • The company surpassed consensus EPS estimates three times over the last four quarters, demonstrating its ability to beat analyst expectations on earnings.
  • The EPS surprise was positive at +3.55% when reported revenues missed the consensus by a negligible -0.12%, highlighting strong earnings performance despite slight revenue miss.
  • Emerson Electric has been rated Zacks Rank #3 (Hold) which indicates it may perform in line with the broader market while maintaining stable fundamentals.
Risk Factors
  • Shares of Emerson Electric (EMR) have underperformed significantly, dropping -17.3% over the past month compared to the Zacks S&P 500 composite's decline of only -6.2%, while its industry peers lost 9.1%.
  • The company was graded D on the Zacks Value Style Score, indicating that its stock is trading at a premium to its peers based on traditional and unconventional valuation metrics.
  • Emerson Electric topped consensus revenue estimates just once over the last four quarters, suggesting inconsistent ability to meet sales targets.
  • The current reported revenues represented a surprise of -0.12% relative to the Zacks Consensus Estimate, indicating minor misses in recent performance.
  • With a Zacks Rank of #3 (Hold), the stock may perform in line with the broader market rather than showing strong upside potential in the near term.
Full Analysis
Emerson Electric Co. (EMR) has recently attracted significant investor attention, ranking among the most searched stocks on Zacks.com despite a recent underperformance relative to benchmarks. Over the past month, EMR shares declined by 17.3%, which contrasts with a -6.2% drop for the S&P 500 composite and a -9.1% loss within the Zacks Manufacturing - Electronics industry. The article highlights that while short-term media releases or rumors may drive stock trends, long-term buy-and-hold decisions are primarily influenced by fundamental facts, specifically changes in earnings projections that determine fair value based on the present value of future earnings streams. Zacks prioritizes evaluating changes in sell-side analyst earnings estimates, noting a strong correlation between these revisions and near-term stock price movements. Current earnings expectations for EMR show a consensus estimate of $1.55 per share for the current quarter, representing a year-over-year increase of 4.7%, with the estimate rising 0.3% over the last 30 days. For the full fiscal year, the consensus estimate stands at $6.50, indicating an 8.3% year-over-year change and a negligible -0.1% revision in the past month. Looking ahead to the next fiscal year, analysts project earnings of $7.14, reflecting a 9.8% expected increase compared to last year's performance with no estimate revisions in the recent period. Revenue analysis further contextualizes EMR's financial health, with consensus sales estimates totaling $4.62 billion for the current quarter (a 4.3% year-over-year growth) and $18.98 billion for the current fiscal year (a 5.4% increase). The company reported actual revenues of $4.35 billion in its last quarter, a slight beat of -0.12% compared to consensus, while earnings per share (EPS) exceeded estimates by 3.55%. Historically, over the last four quarters, Emerson Electric has surpassed EPS estimates three times and revenue estimates once. Regarding valuation, EMR receives a D grade on Zacks Value Style Score, suggesting it is trading at a premium relative to peers across metrics such as price-to-earnings, price-to-sales, and price-to-cash flow. Based on these fundamental factors and the company's Zacks Rank #3 (Hold), the article suggests that while the stock has been heavily searched due to recent activity, its rating indicates it may perform in line with the broader market in the near term rather than outperforming significantly. The consensus view implies that despite the strong earnings growth projections and historical track record of beating EPS estimates, the current valuation premium tempers immediate upside potential. Ultimately, investors are advised to consider both the fundamental trends in earnings and revenue alongside valuation metrics when determining whether EMR warrants attention amidst current market buzz.